- Lobbying
- Lobbying by Verax Biomedical
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Colin Roskey | Health Policy Advisor and Counsel, Senate Finance Committee |
Tom Scully | Administrator & Consultant, CMS; Dep. Asst. to President; Counselor to the Dir., Dir. for Hum. Res. Vets and Labor; Associate Dir. for Legislative Affairs, OMB |
Rudy Missmar | n/a |
Tamara Tenney | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medicare
Q2 Report
Registration
Issue(s) they said they’d lobby about: Hospital Outpatient Prospective Payment - Proposed Rule and Proposed CY2016 Payment Rates; lobbying activity to support federal regulatory strategies at CMS and FDA; no specific legislation..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate